Search research articles
Contact Us
Filters
Showing results (21-30 of 184) with videos related to
Page
of 19
Sort By:
Seminars in Liver Disease
|
February 13, 2016
Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis
Alexander Wree, Wajahat Z Mehal, Ariel E Feldstein
Expert Review of Gastroenterology & Hepatology
|
August 14, 2009
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
Naim Alkhouri, Laura J Dixon, Ariel E Feldstein
Gut
|
September 5, 2018
Liquid biopsy for liver diseases
Jelena Mann, Helen L Reeves, Ariel E Feldstein
Current Opinion in Clinical Nutrition and Metabolic Care
|
December 2, 2016
Update on lipid species and paediatric nonalcoholic fatty liver disease
Jake P Mann, Ariel E Feldstein, Valerio Nobili
The Journal of Biological Chemistry
|
August 6, 2009
Suppression of mitochondrial function by oxidatively truncated phospholipids is reversible, aided by bid, and suppressed by Bcl-XL
Rui Chen, Ariel E Feldstein, Thomas M McIntyre
Expert Review of Gastroenterology & Hepatology
|
April 12, 2011
Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
Naim Alkhouri, Christine Carter-Kent, Ariel E Feldstein
BMC Medicine
|
June 8, 2011
The role of lifestyle changes in the management of chronic liver disease
Valerio Nobili, Christine Carter-Kent, Ariel E Feldstein
Hepatology (Baltimore, Md.)
|
July 31, 2007
Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future
Anna Wieckowska, Arthur J McCullough, Ariel E Feldstein
Seminars in Liver Disease
|
June 12, 2020
The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis
Jana Knorr, Alexander Wree, Frank Tacke, et al.
Nature Reviews. Gastroenterology & Hepatology
|
May 10, 2018
Triggering and resolution of inflammation in NASH
Susanne Schuster, Daniel Cabrera, Marco Arrese, et al.
Page
of 19
Search research articles
Search
Showing results (21-30 of 184) with videos related to
Sort By:
Page
of 19
Seminars in Liver Disease
|
February 13, 2016
Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis
Alexander Wree, Wajahat Z Mehal, Ariel E Feldstein
Expert Review of Gastroenterology & Hepatology
|
August 14, 2009
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
Naim Alkhouri, Laura J Dixon, Ariel E Feldstein
Gut
|
September 5, 2018
Liquid biopsy for liver diseases
Jelena Mann, Helen L Reeves, Ariel E Feldstein
Current Opinion in Clinical Nutrition and Metabolic Care
|
December 2, 2016
Update on lipid species and paediatric nonalcoholic fatty liver disease
Jake P Mann, Ariel E Feldstein, Valerio Nobili
The Journal of Biological Chemistry
|
August 6, 2009
Suppression of mitochondrial function by oxidatively truncated phospholipids is reversible, aided by bid, and suppressed by Bcl-XL
Rui Chen, Ariel E Feldstein, Thomas M McIntyre
Expert Review of Gastroenterology & Hepatology
|
April 12, 2011
Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
Naim Alkhouri, Christine Carter-Kent, Ariel E Feldstein
BMC Medicine
|
June 8, 2011
The role of lifestyle changes in the management of chronic liver disease
Valerio Nobili, Christine Carter-Kent, Ariel E Feldstein
Hepatology (Baltimore, Md.)
|
July 31, 2007
Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future
Anna Wieckowska, Arthur J McCullough, Ariel E Feldstein
Seminars in Liver Disease
|
June 12, 2020
The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis
Jana Knorr, Alexander Wree, Frank Tacke, et al.
Nature Reviews. Gastroenterology & Hepatology
|
May 10, 2018
Triggering and resolution of inflammation in NASH
Susanne Schuster, Daniel Cabrera, Marco Arrese, et al.
Page
of 19